Medication info

CAPD 19 Balance Peritoneal Dialysis Solution (Imported Name: Balance 2.3% glucose, 1.25 mmol Calcium, Peritoneal Dialysis Solution)

Prescription medicationSolutionInjection
Ingredient · strength
Sodium Chloride›11.279gCalcium Chloride Hydrate›0.3675gMagnesium Chloride Hexahydrate›0.2033gGlucose Hydrate›50gSodium Lactate 50%›15.69g
Manufacturer / importer
Fresenius Medical Care Korea Ltd.
Appearance
Colorless and transparent liquid divided into Solution A (left) and Solution B (right) in a λ shape.
Packaging
100 bags/box [2,000mL/bag X 1], 400 bags/box [2,000mL/bag X 4]
Approval status
Active

MFDS item code 200308014 · Notified 2003.07.09 · Insurance code 664300140

Summary

Main use
Peritoneal dialysis in patients with acute or chronic renal failure
Who receives it
Adults
Adult administration
1. The attending physician should adjust the treatment method, number of treatments, exchange volume, dialysis time, and duration according to the patient's symptoms. 3. The dose varies according to body size, and the frequency of fluid exchanges should be appropriately adjusted based on biochemical parameters and fluid balance. In general, in adults, 1.5~2.5L is instilled into the peritoneal cavity per exchange and left in place for 4~8 hours before drainage; this process is performed 3~5 times daily. 4. When a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine's exchange volume. 5. The glucose concentration should be selected according to the patient's ultrafiltration needs and kept as low as possible.

Ingredients

Importer
Fresenius Medical Care Korea Ltd.

Efficacy & effects

Peritoneal dialysis in patients with acute or chronic renal failure

View approved original text

This medication is used for peritoneal dialysis treatment in patients with acute and chronic renal failure.

How it is given

Adult administration

1. The attending physician should adjust the treatment method, number of treatments, exchange volume, dialysis time, and duration according to the patient's symptoms. 3. The dose varies according to body size, and the frequency of fluid exchanges should be appropriately adjusted based on biochemical parameters and fluid balance. In general, in adults, 1.5~2.5L is instilled into the peritoneal cavity per exchange and left in place for 4~8 hours before drainage; this process is performed 3~5 times daily. 4. When a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine's exchange volume. 5. The glucose concentration should be selected according to the patient's ultrafiltration needs and kept as low as possible.

Precautions

This medication is a dialysis solution for peritoneal dialysis, used to remove waste products and excess fluids from the patient's body. Discontinuing peritoneal dialysis prematurely can pose a life-threatening risk, so treatment must be continued strictly according to the physician's instructions. This medication should not be used in patients with certain conditions such as diaphragmatic defects, abdominal burns, or severe peritoneal adhesions. Additionally, avoid administration in patients with lactic acidosis or severe electrolyte imbalances. Patients taking digitalis preparations or suspected of having glucose metabolism disorders should regularly monitor serum potassium and blood glucose levels for careful use. Due to the risk of peritonitis or infection, it is crucial to maintain strict aseptic conditions while using the dialysis solution. During dialysis, regularly check for abnormalities in weight, nutritional status, and electrolyte concentrations. The peritoneal dialysis solution must be used in its sealed container, and if the container is damaged or the solution is cloudy, it should not be used. Pregnant or breastfeeding women should make decisions regarding the use of this medication after thorough consultation with their physician. Dosage for children should be adjusted according to age and weight, while elderly patients should consider the risk of hernia development. Caution is required as overdosage may lead to dehydration, electrolyte imbalance, and hyperglycemia; if issues arise, immediate medical assistance should be sought. Peritoneal dialysis should be performed under medical supervision, and adequate education and guidance are needed for self-administration. This medication is intended solely for peritoneal dialysis and should not be used as an injectable solution. Warming the dialysis solution to body temperature prior to use can help reduce discomfort for the patient. Finally, during the use of this medication, infection prevention and overall health status should be carefully monitored.

Side effects

Abdominal pain, bleeding, peritonitis, turbid effusion, fever, inflammation around the abdominal catheter, flushing, discharge, catheter rupture, drainage difficulty, subcutaneous inflammation, nausea, abdominal pain, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal distension, intestinal obstruction, hypokalemia, hyponatremia, hypocalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia, hypercholesterolemia, hypertriglyceridemia, metabolic acidosis, hypoalbuminemia, hyperglycemia, dyspnea due to diaphragm elevation, pulmonary edema, pleural effusion, secondary hyperparathyroidism, edema, amino acid loss, water-soluble vitamin loss, shoulder pain, muscle cramps, hernia, hydrocele, obesity, weakness, syncope, fatigue, headache, dizziness, tachycardia, hypertension, hypotension, sclerosing encapsulating peritonitis, sepsis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a cool place, as its efficacy may decrease if stored below 4 degrees Celsius; avoid very cold places such as a refrigerator.

Appearance and packaging

Appearance

Colorless and transparent liquid divided into Solution A (left) and Solution B (right) in a λ shape.

Package unit

100 bags/box [2,000mL/bag X 1], 400 bags/box [2,000mL/bag X 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.